KRW 16600.0
(0.36%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 31.6 Billion KRW | 2.44% |
2022 | 30.84 Billion KRW | -7.67% |
2021 | 33.41 Billion KRW | 38.85% |
2020 | 24.06 Billion KRW | 63.79% |
2019 | 14.69 Billion KRW | -3.36% |
2018 | 15.2 Billion KRW | 24.79% |
2017 | 12.18 Billion KRW | 29.36% |
2016 | 9.41 Billion KRW | 79.14% |
2015 | 5.25 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 34.34 Billion KRW | 8.68% |
2024 Q2 | 34.42 Billion KRW | 0.24% |
2023 Q2 | 29.6 Billion KRW | -2.97% |
2023 Q4 | 31.6 Billion KRW | 3.86% |
2023 FY | 31.6 Billion KRW | 2.44% |
2023 Q3 | 30.42 Billion KRW | 2.77% |
2023 Q1 | 30.51 Billion KRW | -1.08% |
2022 Q1 | 35.9 Billion KRW | 7.47% |
2022 Q3 | 34.49 Billion KRW | -8.68% |
2022 Q2 | 37.77 Billion KRW | 5.21% |
2022 Q4 | 30.84 Billion KRW | -10.57% |
2022 FY | 30.84 Billion KRW | -7.67% |
2021 FY | 33.41 Billion KRW | 38.85% |
2021 Q1 | 27.06 Billion KRW | 12.47% |
2021 Q2 | 29.26 Billion KRW | 8.15% |
2021 Q3 | 29.47 Billion KRW | 0.7% |
2021 Q4 | 33.41 Billion KRW | 13.36% |
2020 Q2 | 24.73 Billion KRW | 48.24% |
2020 Q4 | 24.06 Billion KRW | 0.43% |
2020 Q3 | 23.96 Billion KRW | -3.14% |
2020 Q1 | 16.68 Billion KRW | 13.59% |
2020 FY | 24.06 Billion KRW | 63.79% |
2019 Q2 | 15.44 Billion KRW | -1.39% |
2019 FY | 14.69 Billion KRW | -3.36% |
2019 Q4 | 14.69 Billion KRW | -1.86% |
2019 Q3 | 14.96 Billion KRW | -3.06% |
2019 Q1 | 15.65 Billion KRW | 3.0% |
2018 Q2 | 16.15 Billion KRW | 19.81% |
2018 FY | 15.2 Billion KRW | 24.79% |
2018 Q4 | 15.2 Billion KRW | -5.01% |
2018 Q1 | 13.48 Billion KRW | 10.7% |
2018 Q3 | 16 Billion KRW | -0.96% |
2017 FY | 12.18 Billion KRW | 29.36% |
2017 Q1 | 10.8 Billion KRW | 14.75% |
2017 Q2 | 11.77 Billion KRW | 8.93% |
2017 Q3 | 12.72 Billion KRW | 8.07% |
2017 Q4 | 12.18 Billion KRW | -4.24% |
2016 Q3 | 8.78 Billion KRW | 9.41% |
2016 Q1 | 8.28 Billion KRW | 57.68% |
2016 Q2 | 8.02 Billion KRW | -3.15% |
2016 FY | 9.41 Billion KRW | 79.14% |
2016 Q4 | 9.41 Billion KRW | 7.22% |
2015 Q3 | 4.98 Billion KRW | 0.0% |
2015 FY | 5.25 Billion KRW | 0.0% |
2015 Q4 | 5.25 Billion KRW | 5.43% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | 20.85 Billion KRW | -51.514% |
CMG Pharmaceutical Co., Ltd. | 15.87 Billion KRW | -99.064% |
Celltrion Pharm, Inc. | 100.42 Billion KRW | 68.529% |
Huons Global Co., Ltd. | 121.81 Billion KRW | 74.057% |
DongKook Pharmaceutical Co., Ltd. | 138.34 Billion KRW | 77.156% |
Enzychem Lifesciences Corporation | 14.94 Billion KRW | -111.45% |
Humedix Co., Ltd. | 28.62 Billion KRW | -10.402% |
EuBiologics Co., Ltd. | 13.34 Billion KRW | -136.877% |
FutureChem Co.,Ltd | 1.37 Billion KRW | -2199.225% |
Huons Co., Ltd. | 76.59 Billion KRW | 58.742% |
BNC Korea Co., Ltd. | 11.39 Billion KRW | -177.378% |
AptaBio Therapeutics Inc. | - KRW | -Infinity% |